JK-1 inhibitors refer to a class of chemical compounds that are known to selectively target and inhibit the activity of JK-1, a specific enzyme or protein involved in cellular processes. These inhibitors typically function by binding to the active site or an allosteric site of the JK-1 protein, preventing it from carrying out its biological role. The structure of JK-1 inhibitors is often characterized by a highly specific molecular framework that allows for strong interactions with the enzyme, ensuring both high affinity and selectivity. Modifications to various functional groups within these molecules are common, enhancing their ability to disrupt the protein's activity without affecting similar enzymes or proteins in the cell. Such chemical precision in targeting helps maintain the integrity of other cellular processes while blocking the function of JK-1.
The development of JK-1 inhibitors usually involves extensive structure-activity relationship (SAR) studies, which focus on identifying the molecular features responsible for effective inhibition. In these studies, variations in the chemical structure of potential inhibitors are systematically tested to determine their impact on binding affinity and inhibitory potency. Many JK-1 inhibitors are designed to have high stability, solubility, and bioavailability in various experimental settings. Researchers typically optimize the core structure of these compounds through techniques like computational modeling, high-throughput screening, and molecular docking to predict and enhance their interaction with the JK-1 protein. Such inhibitors are invaluable in laboratory studies for elucidating the biological functions of JK-1 and investigating its role in cellular pathways, gene expression regulation, and intracellular signaling mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could hypothetically lead to hypomethylation of the JK-1 gene, resulting in the downregulation of its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A might cause chromatin remodeling that could decrease JK-1 transcriptional activity. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin could potentially inhibit JK-1 expression by stabilizing the DNA-topoisomerase I complex, interfering with transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This compound could intercalate into DNA and inhibit RNA polymerase movement, leading to a decrease in JK-1 mRNA synthesis. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Pladienolide B might disrupt the proper splicing of JK-1 pre-mRNA, potentially resulting in nonfunctional mRNA and reduced protein levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide might inhibit the ribosomal translocation, thus hindering the elongation phase during JK-1 protein synthesis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib could increase the degradation of transcriptional activators necessary for JK-1 expression, indirectly reducing its protein levels. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide may inhibit the transcription of JK-1 by downregulating heat shock proteins and transcription factors essential for its expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 might bind to the bromodomain of BET proteins, which could lead to the repression of transcriptional activity at the JK-1 locus. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 could lead to the demethylation of the JK-1 gene promoter and suppress its transcriptional initiation and expression. | ||||||